Top Institutional Investors

ABG-WTT Global Life Science Capital Partners GP Ltd — 13F Holdings & Portfolio

CIK 1832108 · latest 13F-HR filed 2026-05-18

Backtest portfolio

ABG-WTT Global Life Science Capital Partners GP Ltd manages $12.3M in 13F-reported U.S. long-equity assets across 2 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are CBLL (65.87%), RPID (34.13%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 0 new positions, exited 0, added to 0, and trimmed 2.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$12.3M

Long-equity book

Holdings

2

Distinct positions

Period

2026-03-31

Filed 2026-05-18

Q/Q Activity

+0 / −0 / ↑0 / ↓2

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • No increased positions.
Show all 0 →

Top Trims

  • CERIBELL INC-$1.6M -16.4%
  • RAPID MICRO BIOSYSTEMS INC-$1.2M -21.7%
Show all 2 →

New Positions

  • No new positions this quarter.
Show all 0 →

Exited Positions

  • No exits this quarter.
Show all 0 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 CERIBELL INC CBLL 15678C102 $8.1M 65.87% 441,820 SH
2 RAPID MICRO BIOSYSTEMS INC RPID 75340L104 $4.2M 34.13% 1,848,296 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-18 $12.3M 2 0001193125-26-227557
2025-12-31 2026-02-17 $15.0M 2 0001193125-26-055042
2025-09-30 2025-11-14 $18.7M 2 0001193125-25-283037